These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6978333)

  • 41. Can the Etest correctly determine the MICs of beta-lactam and cephalosporin antibiotics for beta-lactamase-negative ampicillin-resistant Haemophilus influenzae?
    Billal DS; Hotomi M; Yamanaka N
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3463-4. PubMed ID: 17606681
    [No Abstract]   [Full Text] [Related]  

  • 42. In-vitro activity and beta-lactamase stability of Sch 29482, a penem antibiotic. Comparisons with ceftazidime and moxalactam.
    Dornbusch K; Adamsson L; Gezelius L; Hallander H
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():113-21. PubMed ID: 6460739
    [No Abstract]   [Full Text] [Related]  

  • 43. Beta-lactamases in anaerobic bacteria.
    Nord CE; Lindqvist L; Olsson-Liljequist B; Tunér K
    Scand J Infect Dis Suppl; 1985; 46():57-63. PubMed ID: 3877980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sch 29482: stability and inhibitory potency towards beta-lactamases from Gram-negative bacteria.
    Pechère JC; Letarte R; Guay R; Asselin C; Morin C
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():123-32. PubMed ID: 6977528
    [No Abstract]   [Full Text] [Related]  

  • 45. Beta-lactam resistance in anaerobic bacteria: a review.
    Hedberg M; Nord CE
    J Chemother; 1996 Feb; 8(1):3-16. PubMed ID: 8835102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Induction of beta-lactamases in Enterobacter cloacae with beta-lactam antibiotics].
    Cullmann W; Dick W
    Immun Infekt; 1984 Feb; 12(1):29-34. PubMed ID: 6335880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multicentre survey of the antibiotic susceptibility of clinical Bacteroides species from Hungary.
    Sárvári KP; Sóki J; Kristóf K; Juhász E; Miszti C; Latkóczy K; Melegh SZ; Urbán E
    Infect Dis (Lond); 2018 May; 50(5):372-380. PubMed ID: 29303023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The antibacterial activity of thienamycin against multiresistant bacteria-comparison with beta-lactamase stable compounds.
    Romagnoli MF; Fu KP; Neu HC
    J Antimicrob Chemother; 1980 Sep; 6(5):601-6. PubMed ID: 6967870
    [No Abstract]   [Full Text] [Related]  

  • 49. Evaluation of a new meropenem-EDTA double-ended Etest strip for the detection of the cfiA metallo-beta-lactamase gene in clinical isolates of Bacteroides fragilis.
    Bogaerts P; Engelhardt A; Berhin C; Bylund L; Ho P; Yusof A; Glupczynski Y
    Clin Microbiol Infect; 2008 Oct; 14(10):973-7. PubMed ID: 18828856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modern beta-lactam antibiotics.
    Sykes RB; Bonner DP; Swabb EA
    Pharmacol Ther; 1985; 29(3):321-52. PubMed ID: 3915359
    [No Abstract]   [Full Text] [Related]  

  • 51. [Can meropenem E-test be used to estimate the presence of carbapenem resistance gene cfiA among Bacteroides fragilis strains?].
    Toprak Ülger N; Ilki A; Ozel N; Balkan N; Söyletir G
    Mikrobiyol Bul; 2011 Jul; 45(3):385-91. PubMed ID: 21935771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A study of the beta-lactamases of 100 clinical isolates of Yersinia enterocolitica.
    Pham JN; Bell SM; Lanzarone JY
    J Antimicrob Chemother; 1991 Jul; 28(1):19-24. PubMed ID: 1769940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem.
    Eley A; Greenwood D
    J Med Microbiol; 1986 Feb; 21(1):49-57. PubMed ID: 3485198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
    Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
    J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PS-5 inhibition of a beta-lactamase from Proteus vulgaris.
    Okamura K; Sakamoto M; Ishikura T
    J Antibiot (Tokyo); 1980 Mar; 33(3):293-302. PubMed ID: 6991465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resistance of Bacteroides isolates recovered among clinical samples from a major Costa Rican hospital between 2000 and 2008 to ß-lactams, clindamycin, metronidazole, and chloramphenicol.
    Cordero-Laurent E; Rodríguez C; Rodríguez-Cavallini E; Gamboa-Coronado MM; Quesada-Gómez C
    Rev Esp Quimioter; 2012 Dec; 25(4):261-5. PubMed ID: 23303257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of beta-lactamases on the antibacterial activity of carumonam and aztreonam against Klebsiella sp. in comparison with 4 other beta-lactams].
    Labia R; Morand A; Pitton JS; Philippin JL; Fournier P
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):796-9. PubMed ID: 3309817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
    Medeiros AA; Hare R; Papa E; Adam C; Miller GH
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.
    Rotschafer JC; Ostergaard BE
    Am J Health Syst Pharm; 1995 Mar; 52(6 Suppl 2):S15-22. PubMed ID: 7606585
    [TBL] [Abstract][Full Text] [Related]  

  • 60. β-Lactamases: Why and How.
    Pratt RF
    J Med Chem; 2016 Sep; 59(18):8207-20. PubMed ID: 27232275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.